DIASORIN S.P.A.

DIASORIN S.P.A. Overview

Company Headquarters: Saluggia, Italy

Founded: 2000

Workforce: ~ 1,971

Company Working:

DIASORIN S.P.A. is an Italian multinational group and a global leader in the in-vitro diagnostics market. It is one of the listed companies on MTA (Mercato Telematico Azionario) in the FTSE Italia Mid Cap Index, organized and managed by Borsa Italiana S.p.A. It provides its services to hospitals, private testing laboratories of immunodiagnostics, and molecular diagnostics. It is one of the leading healthcare companies that provide services to about 4000 US hospitals and health systems and approximately 165,000 other providers and healthcare organizations. It provides services at lower costs to hospitals and other pharmaceutical industries.

Strategy

DIASORIN S.P.A. strategizes to market chemiluminescence immunoassay analyzers, products, and services to healthcare providers such as health systems and acute care hospitals. It has products that increase patients’ and users’ comfort, make laboratory work more efficient, and thus help to improve healthcare facilities worldwide, in the long term. It also invests in research and development to know the future trends and to determine the needs of its customers.

Company Snapshot

$635M

Revenue

1,971

Employees

2000

Founded

Saluggia, Italy

Headquarters

SWOT Analysis

Strengths

High quality products
Strong R&D
Strong presence in the domestic market

Weaknesses

Strong competition from international giants
Limited presence in developing countries

Opportunities

Product portfolio expansion

Threats

Average financial performance
Limited customers
Foreign exchange

Key Developments

Date	Approach	Development
July 2018	Product Launch	DiaSorin and QIAGEN N.V. announced the launch of the LIAISON QuantiFERON-TB Gold Plus. It detects latent tuberculosis infection (LTBI) on LIAISON analyzer systems. This new test was developed in a partnership between DiaSorin and QIAGEN.
February 2018	Agreement	DIASORIN S.P.A. and the Trivitron Healthcare Group concluded a deal, according to which Trivitron Healthcare sold its minority interest (49%) held in the joint venture to the US company DiaSorin Inc., for a consideration of EUR 3.5 million.

Product Offering

DIASORIN S.P.A.
- Chemiluminescence Immunoassay (CLIA) Analyzers

Financial Performance

What our clients say

Trusted by forward-thinking businesses
for data-driven intelligence

Noah Malgeri

Co-Founder, Mojave Rail Fabrication Limited

This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.

Michael Robert

Manager, JavolVision

Thanks, I am so happy that we worked together. Maybe we still can work together in the future.

Joseph Aguayo

Sales Operations & Pricing Manager, Intel

Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.

Bong Lau

Sales Leader, Bamberg

We bought your "2025 report" in 2020. Everything is fine and very good.

Peter Groot Koerkamp

Account and Business Manager, EFS-Holland BV

Thanks for sending the report it gives us a good global view of the Betaïne market.

Younghwan Choi

Senior Retail Manager, LG Chem

We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.

Mark Irwin

Management Consultant, Level 21

I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.

Rob Kooiker

Group Product Manager HVAC & Fire Protection GMA, Rockwool

I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!

Jason Lee

R&D Director, Seojin

Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.

Akif Moroglu

Strategy & Business Development Director, Dogan Holding

We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.